刺激性和幻觉性新型精神活性物质;一个更新
F Schifano1, A Vento2, N Scherbaum3
1Psychopharmacology Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Herts (UK).
本综述涵盖了兴奋剂,迷幻药和解离剂,详细说明了它们的临床和药理学特征. 了解新型精神活性物质 (NPS) 对临床医生来说至关重要,以管理相关风险并指导未来的治疗研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 临床医学 临床医学
背景情况:
- 对兴奋剂,迷幻药和离散剂的治疗应用越来越感兴趣.
- 需要对这些物质的临床和药理方面的最新概述.
- 专注于新型精神活性物质 (NPS) 及其影响.
研究的目的:
- 提供关于兴奋剂,古典和非典型迷幻药的全面概述.
- 阐明药理机制,包括对多巴胺和血清素的影响.
- 告知临床医生关于与NPS相关的风险.
主要方法:
- 审查关于兴奋剂,迷幻药和离散剂的现有文献.
- 药理作用的分析,包括受体相互作用 (例如DA,5-HT,NMDA).
- 临床和精神病学数据的综合.
主要成果:
- 兴奋剂和迷幻药调节中央多巴胺 (DA) 水平.
- 通过某些迷幻药物激活血清素 (5-HT) 受体亚型.
- 在类似芬西克利丁的分离剂中观察到的NMDA受体对抗性.
结论:
- 临床医生需要定期更新NPS及其医疗,精神生物学和精神病理风险.
- 未来的研究应该整合计算化学和对新型精神活性药物的先进临床前研究.
- 迷幻药物研究应优先考虑强大的研究设计,以评估治疗益处和低依赖责任.
更多相关视频
11:14Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
Published on: October 2, 2016
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
相关概念视频
CNS Stimulants: Psychedelic Agents
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
